Navigation Links
Wristbands ease nausea with cancer treatment
Date:4/8/2009

Cancer patients who wore acupressure wristbands had much less nausea while receiving radiation treatment, making the bands a safe, low-cost addition to anti-nausea medication, according to a study published in the Journal of Pain and Symptom Management by University of Rochester Medical Center researchers.

Previous research has suggested that the placebo effect essentially, an outcome related to your body that you expect to happen might be why elastic wristbands reduce nausea. However, the findings of the latest study do not support that notion, even though researchers continue to believe in the mind's powerful influence over symptoms.

"We know the placebo effect exists, the problem is that we don't know how to measure it very well," said Joseph A. Roscoe, Ph.D., corresponding author and research associate professor at the James P. Wilmot Cancer Center at URMC. "In this study we attempted to manipulate the information we gave to patients, to see if their expectations about nausea could be changed. As it turned out, our information to change people's expectations had no effect but we still found that the wristbands reduce nausea symptoms."

The clinical trial enrolled 88 people divided into three groups. All had reported some degree of nausea after receiving at least two radiation treatments for any type of cancer. Although chemotherapy is more closely linked with producing nausea and vomiting, radiation to the intestinal tract can also cause nausea, Roscoe said.

Patients without wristbands, or group 1, served as the control group. The patients who wore wristbands were divided into two groups. Group 2 received an informational handout explaining that in previous research, wristbands were found to reduce nausea. The handout also showed two bar graphs reflecting a reduction in nausea among people who wear the bands. Group 3 also received a handout, but the information was more neutral.

The result: a 23.8 percent decrease in nausea for all the patients who wore wristbands, compared to a 4.8 percent decrease in the control group. But when researchers analyzed whether any differences existed between the two wristband groups, none was found.

"Some of our body's feelings and sensations are ambiguous and subject to interpretation," Roscoe explained. "Your mind cannot make a blister go away, or reduce hair loss, but it can interpret ambiguous abdominal sensations and decide how much nausea they represent, based on our expectations."

Roscoe has conducted several previous studies of how expectations influence treatment side effects, and how wristbands can ease chemotherapy-related nausea. The American Cancer Society funded the current study.

Targeting the wrist as a nausea point is a staple of Chinese acupuncture medicine. Stimulating that point on the wrist with a needle or the pressure of an elastic band is said to unblock the flow of universal chi energy.


'/>"/>

Contact: Leslie Orr
Leslie_Orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort
2. No Link Between Anti-Nausea Drug, Heart Trouble
3. Acupuncture does not reduce radiotherapy-induced nausea, but patients believe it does
4. Mayo Clinic study finds FDA warning against antinausea drug droperidol unnecessary
5. Explaining chemotherapy-associated nausea
6. FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
7. SANCUSO(R), the First and Only Patch for Preventing Nausea and Vomiting in Chemotherapy Patients, Now Available
8. Oncologists Rank Aloxis Marketing Message Most Influential in the Chemotherapy-Induced Nausea and Vomiting Drug Market
9. Nausea Drug Shows Promise Against Opioid Addiction
10. Scientists trial device to treat chemotherapy-related nausea
11. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a family ... and Raleigh regions, is organizing an extended charity drive to benefit the family ... abnormality. , After struggling since birth with several health challenges, T.J. was later ...
(Date:10/13/2017)... ... October 13, 2017 , ... The ... to promote standards of excellence for the field of eating disorders, announces the ... – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: